Increased Efferent Cardiac Sympathetic Nerve Activity and Defective Intrinsic Heart Rate Regulation in Type 2 Diabetes

Diabetes
H P Aye ThaungRegis R Lamberts

Abstract

Elevated sympathetic nerve activity (SNA) coupled with dysregulated β-adrenoceptor (β-AR) signaling is postulated as a major driving force for cardiac dysfunction in patients with type 2 diabetes; however, cardiac SNA has never been assessed directly in diabetes. Our aim was to measure the sympathetic input to and the β-AR responsiveness of the heart in the type 2 diabetic heart. In vivo recording of SNA of the left efferent cardiac sympathetic branch of the stellate ganglion in Zucker diabetic fatty rats revealed an elevated resting cardiac SNA and doubled firing rate compared with nondiabetic rats. Ex vivo, in isolated denervated hearts, the intrinsic heart rate was markedly reduced. Contractile and relaxation responses to β-AR stimulation with dobutamine were compromised in externally paced diabetic hearts, but not in diabetic hearts allowed to regulate their own heart rate. Protein levels of left ventricular β1-AR and Gs (guanine nucleotide binding protein stimulatory) were reduced, whereas left ventricular and right atrial β2-AR and Gi (guanine nucleotide binding protein inhibitory regulatory) levels were increased. The elevated resting cardiac SNA in type 2 diabetes, combined with the reduced cardiac β-AR responsiveness, ...Continue Reading

References

Jul 5, 1975·British Medical Journal·R H Lloyd-Mostyn, P J Watkins
Jan 1, 1985·Journal of Cardiovascular Pharmacology·F L AtkinsS Love
Dec 1, 1986·Circulation Research·P K GangulyN S Dhalla
Jan 1, 1984·Canadian Journal of Physiology and Pharmacology·R V Vadlamudi, J H McNeill
Jan 20, 1995·Journal of the Autonomic Nervous System·G JokkelM Kollai
Oct 1, 1993·Journal of the American College of Cardiology·M R Bristow
Aug 1, 1993·British Journal of Pharmacology·S GandoM Kanno
Aug 1, 1996·Current Opinion in Lipidology·P N HopkinsR R Williams
Feb 7, 1998·Hypertension·E W ShekJ E Hall
Aug 17, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·S F Morrison
Dec 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·David L JardineHamid Ikram
Dec 17, 2003·Circulation·Robert J HuggettDavid A S G Mary
Jan 15, 2004·American Journal of Physiology. Endocrinology and Metabolism·Peipei Wang, John C Chatham
May 5, 2005·The European Journal of Neuroscience·Adele G WoolleyMarilyn J Duxson
Oct 31, 2006·Journal of Molecular and Cellular Cardiology·Andrea BarbutiDario DiFrancesco
Jan 24, 2007·Circulation·Aaron I Vinik, Dan Ziegler
Mar 21, 2007·American Journal of Physiology. Heart and Circulatory Physiology·D L JardineA M Richards
Apr 17, 2007·American Journal of Physiology. Heart and Circulatory Physiology·A M D WatsonC N May
Jul 10, 2007·Metabolism: Clinical and Experimental·Michael A MaloneJohn I Malone
Jun 19, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·R RamchandraC N May
Jul 21, 2009·Experimental Physiology·C N MayR Ramchandra
Aug 28, 2009·The New England Journal of Medicine·Markus P SchlaichMurray D Esler
Aug 31, 2010·Journal of Molecular and Cellular Cardiology·Giuseppe RengoWalter J Koch
Mar 9, 2011·Circulation·Peter H Brubaker, Dalane W Kitzman
Apr 7, 2011·Life Sciences·Joaquín Pérez-SchindlerJesús Hernández-Cascales

❮ Previous
Next ❯

Citations

Dec 17, 2016·Medicine and Science in Sports and Exercise·Genevieve Abigail WilsonJames Chris Baldi
Jul 19, 2017·Physiological Reports·Carol T Bussey, Regis R Lamberts
Jun 7, 2018·Experimental Physiology·Carol T BusseyRegis R Lamberts
Oct 20, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Kazuhiro KamadaHiroyuki Tsutsui
Jan 15, 2019·Medicine and Science in Sports and Exercise·Genevieve A WilsonJames C Baldi
Sep 24, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Yomna M YehyaMohamed E Sarhan
Sep 5, 2020·Drug Design, Development and Therapy·Gizele Cabral CostaGisele Zapata-Sudo
Dec 12, 2018·Frontiers in Physiology·Laurel A Grisanti
Dec 2, 2020·Cells·Betul R ErdoganEbru Arioglu-Inan
Apr 21, 2020·Endocrine, Metabolic & Immune Disorders Drug Targets·Abdelaziz M HusseinLashin S Lashin
Feb 21, 2021·Clinical and Experimental Pharmacology & Physiology·Ahmed SultanFrank Christopher Howarth

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.